Skip to content

Author

Xue-Bing Yan

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Jujuboside A ameliorates T2DM-associated MASH: Suppression of YY1/FAS axis-mediated hepatic de novo fatty acid biosynthesis.

Metabolic dysfunction-associated steatohepatitis (MASH) in type 2 diabetes mellitus (T2DM) represents a progressive subtype of metabolic dysfunction-associated steatotic liver disease (MASLD), and is predominantly driven by dysregulated hepatic fatty acid (FA) metabolism. Although Jujuboside A (Ju A), a major bioactive...

Ting-Ting Yang, Li-Bang Chen, Hao-Nan Luo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.